Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Plaintiffs of Iressa cancer drug case

TOKYO, Japan - Three deceased patients' relatives who sued the Japanese government and the Japanese unit of British pharmaceutical company AstraZeneca PLC, demanding compensation for the side effects caused by the lung cancer drug Iressa, walk to the Tokyo High Court on Nov. 15, 2011. The high court on the same day ruled the government and AstraZeneca K.K. are not responsible for damages, overturning a lower court ruling. The plaintiffs sought a combined 77 million yen in compensation.

E

AstraZeneca ordered to pay damages over side-effects of Iressa

OSAKA, Japan - Supporters of plaintiffs hold up banners in front of the Osaka District Court on Feb. 25, 2011, declaring victory in their case after the court ordered the Japan unit of British drugmaker AstraZeneca PLC to pay a total of 60.5 million yen to nine of 11 plaintiffs who sought compensation over side-effects caused by the lung cancer drug Iressa.

E

AstraZeneca ordered to pay damages over side-effects of Iressa

OSAKA, Japan - Hideki Shimizu (R), a plaintiff who demanded compensation over side effects caused by the lung cancer drug Iressa, speaks at a press conference in Osaka on Feb. 25, 2011, together with Akio Chikazawa, a plaintiff in a similar suit filed in Tokyo. The Osaka District Court the same day ordered the Japan unit of British drugmaker AstraZeneca PLC to pay a total of 60.5 million yen to nine out of 11 plaintiffs, including Shimizu.

E

Settlement plan for Iressa drug damages suits rejected

TOKYO, Japan - Japanese health minister Ritsuo Hosokawa announces the government's decision to reject a court settlement plan for damages suits over side effects caused by the lung cancer drug Iressa in a press conference at the ministry in Tokyo on Jan. 28, 2011.

E

Kin sue state, distributor over side-effects of Iressa cancer drug

TOKYO, Japan - Akio Chikazawa speaks to reporters in Tokyo on Nov. 25 after filing a damages suit against the state and AstraZeneca K.K., the Osaka-based Japanese subsidiary of British pharmaceutical company AstraZeneca PLC, the maker and distributor of the lung cancer drug Iressa, for alleged failure to inform doctors of the risk of serious side-effects.

E

Death toll from anticancer drug rises to over 100 in Japan

TOKYO, Japan - Nearly 500 people experienced debilitating side effects from an anticancer British-made drug called Iressa (in file photo), resulting in more than 100 deaths in Japan, the Ministry of Health, Labor and Welfare said Dec. 25. As of Dec. 13, of the 358 people who experienced side effects such as pneumonia and lung damage, 114 died, the ministry said.

E

Kin sue state, distributor over side-effects of Iressa cancer dr

TOKYO, Japan - Akio Chikazawa speaks to reporters in Tokyo on Nov. 25 after filing a damages suit against the state and AstraZeneca K.K., the Osaka-based Japanese subsidiary of British pharmaceutical company AstraZeneca PLC, the maker and distributor of the lung cancer drug Iressa, for alleged failure to inform doctors of the risk of serious side-effects. (Kyodo)

E

AstraZeneca ordered to pay damages over side-effects of Iressa

OSAKA, Japan - Hideki Shimizu (R), a plaintiff who demanded compensation over side effects caused by the lung cancer drug Iressa, speaks at a press conference in Osaka on Feb. 25, 2011, together with Akio Chikazawa, a plaintiff in a similar suit filed in Tokyo. The Osaka District Court the same day ordered the Japan unit of British drugmaker AstraZeneca PLC to pay a total of 60.5 million yen to nine out of 11 plaintiffs, including Shimizu. (Kyodo)

E

AstraZeneca ordered to pay damages over side-effects of Iressa

OSAKA, Japan - Supporters of plaintiffs hold up banners in front of the Osaka District Court on Feb. 25, 2011, declaring victory in their case after the court ordered the Japan unit of British drugmaker AstraZeneca PLC to pay a total of 60.5 million yen to nine of 11 plaintiffs who sought compensation over side-effects caused by the lung cancer drug Iressa. (Kyodo)

E

Settlement plan for Iressa drug damages suits rejected

TOKYO, Japan - Japanese health minister Ritsuo Hosokawa announces the government's decision to reject a court settlement plan for damages suits over side effects caused by the lung cancer drug Iressa in a press conference at the ministry in Tokyo on Jan. 28, 2011. (Kyodo)

E

Plaintiffs of Iressa cancer drug case

TOKYO, Japan - Three deceased patients' relatives who sued the Japanese government and the Japanese unit of British pharmaceutical company AstraZeneca PLC, demanding compensation for the side effects caused by the lung cancer drug Iressa, walk to the Tokyo High Court on Nov. 15, 2011. The high court on the same day ruled the government and AstraZeneca K.K. are not responsible for damages, overturning a lower court ruling. The plaintiffs sought a combined 77 million yen in compensation. (Kyodo)

E

Death toll from anticancer drug rises to over 100 in Japan

TOKYO, Japan - Nearly 500 people experienced debilitating side effects from an anticancer British-made drug called Iressa (in file photo), resulting in more than 100 deaths in Japan, the Ministry of Health, Labor and Welfare said Dec. 25. As of Dec. 13, of the 358 people who experienced side effects such as pneumonia and lung damage, 114 died, the ministry said. (Kyodo)